News
SBMFF
0.778
NaN%
--
Weekly Report: what happened at SBMFF last week (0302-0306)?
Weekly Report · 13h ago
Sanofi bets up to $1.53B to license blood cancer drug from Sino Biopharma unit
Seeking Alpha · 5d ago
Sino Biopharm Grants Sanofi Global Rights to First-in-Class JAK/ROCK Drug Rovadicitinib
TipRanks · 6d ago
Weekly Report: what happened at SBMFF last week (0223-0227)?
Weekly Report · 03/02 10:08
Sino Biopharm Wins China Approval for First-in-Class Myelofibrosis Drug
TipRanks · 03/01 22:37
Weekly Report: what happened at SBMFF last week (0216-0220)?
Weekly Report · 02/23 10:08
Weekly Report: what happened at SBMFF last week (0209-0213)?
Weekly Report · 02/16 10:08
Sino Biopharm Wins China Nod for New Lung Cancer Use of PD-L1 Drug
TipRanks · 02/15 23:07
Sino Biopharm Completes Phase III Enrollment for Next-Gen HER2-Low Breast Cancer Drug
TipRanks · 02/09 22:40
Bernstein Remains a Hold on Sino Biopharmaceutical (SBMFF)
TipRanks · 02/09 16:35
Weekly Report: what happened at SBMFF last week (0202-0206)?
Weekly Report · 02/09 10:09
Sino Biopharm’s CLDN18.2 ADC Becomes First to Complete Phase III Enrollment
TipRanks · 02/08 22:38
Weekly Report: what happened at SBMFF last week (0126-0130)?
Weekly Report · 02/02 10:09
BOCOM International Holdings Company Sticks to Its Buy Rating for Sino Biopharmaceutical (SBMFF)
TipRanks · 01/31 17:55
Sino Biopharm’s Hepatitis B Drug TQA3605 Hits Key Goal in Phase II Trial
TipRanks · 01/27 08:38
Weekly Report: what happened at SBMFF last week (0119-0123)?
Weekly Report · 01/26 10:09
Weekly Report: what happened at SBMFF last week (0112-0116)?
Weekly Report · 01/19 10:14
CICC Reaffirms Their Buy Rating on Sino Biopharmaceutical (SBMFF)
TipRanks · 01/15 05:06
Sino Biopharm Buys siRNA Specialist Hygieia in RMB1.2 Billion Chronic Disease Push
TipRanks · 01/13 10:09
Sino Biopharm Appoints New Company Secretary and Authorised Representative
TipRanks · 01/13 10:07
More
Webull provides a variety of real-time SBMFF stock news. You can receive the latest news about Sino Biopharmaceutical Limited through multiple platforms. This information may help you make smarter investment decisions.
About SBMFF
Sino Biopharmaceutical Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company operates its business through three segments. The Modernised Chinese Medicines and Chemical Medicines segment is mainly engaged in the manufacture, sale and distribution of modernised Chinese medicine products and western medicine products. The Investment segment is mainly engaged in the long term investments business. The Others segment is mainly engaged in the related healthcare and hospital business.